Start-up company Bexion Pharmaceuticals uses ezone grant money to develop therapies against cancer
Dr. Ray Takigiku, CEO of Northern Kentucky-based Bexion Pharmaceuticals recently appeared on Fifth Third’s Business Beat to talk about his company’s advancements in cancer treatment and therapy. New funding from the Northern Kentucky ezone will help in taking these advancements out of the lab and into the clinic where they can do the most good for the most people. Cancer research over the past few decades has come a long way. Now with the help of Bexion’s unique approach to tumor therapy, that research shows great promise for a number of cancer treatments. To see the full video, click here. Source: CET ConnectWriter: Jeff Syroney
Dr. Ray Takigiku, CEO of Northern Kentucky-based Bexion Pharmaceuticals recently appeared on Fifth Third’s Business Beat to talk about his company’s advancements in cancer treatment and therapy. New funding from the Northern Kentucky ezone will help in taking these advancements out of the lab and into the clinic where they can do the most good for the most people.
Cancer research over the past few decades has come a long way. Now with the help of Bexion’s unique approach to tumor therapy, that research shows great promise for a number of cancer treatments. To see the full video, click here.
Source: CET Connect
Writer: Jeff Syroney
Author
